Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net income $ 1,786,002 $ 877,125
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 170,369 164,323
Unrealized foreign exchange (gain) loss and other 21,728 (18,570)
Asset impairment charges 5,962 865
Stock-based compensation expense 52,982 53,819
Deferred income taxes (371,228) (39,507)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (444,685) (117,189)
Inventories (239,890) (112,206)
Other assets 2,243 (11,780)
Accounts payable 40,579 (1,783)
Deferred system revenue 145,856 (61,595)
Deferred service revenue 33,468 (1,431)
Other liabilities 471,209 341,181
Net cash provided by operating activities 1,674,595 1,073,252
Cash flows from investing activities:    
Proceeds from sale of assets 0 1,855
Business acquisitions, net of cash acquired (37,986) 0
Capital expenditures (133,856) (115,069)
Purchases of available-for-sale securities (525,840) (492,048)
Proceeds from sale of available-for-sale securities 40,792 110,812
Proceeds from maturity of available-for-sale securities 372,953 259,327
Purchases of trading securities (58,342) (35,371)
Proceeds from sale of trading securities 59,914 39,668
Proceeds from other investments 795 614
Net cash used in investing activities (281,570) (230,212)
Cash flows from financing activities:    
Proceeds from issuance of debt, net of issuance costs 0 40,343
Proceeds from revolving credit facility 300,000 0
Repayment of debt (300,000) (50,000)
Common stock repurchases (829,551) (365,389)
Payment of dividends to stockholders (321,950) (280,748)
Issuance of common stock 36,912 26,356
Tax withholding payments related to vested and released restricted stock units (52,287) (36,145)
Net cash used in financing activities (1,166,876) (665,583)
Effect of exchange rate changes on cash and cash equivalents (3,702) 19,600
Net increase in cash and cash equivalents 222,447 197,057
Cash and cash equivalents at beginning of period 1,434,610 1,234,409
Cash and cash equivalents at end of period 1,657,057 1,431,466
Supplemental cash flow disclosures:    
Income taxes paid 226,943 113,949
Interest paid 76,771 76,996
Non-cash activities:    
Contingent consideration (receivable) payable - financing activities 14,663 (8,748)
Dividends payable - financing activities 3,737 3,321
Unsettled common stock repurchase - financing activities 5,999 6,000
Accrued purchases of land, property and equipment - investing activities $ 18,504 $ 25,987